Muslim Council of Britain elects first female secretary general

Megan Baynes, PA
·2-min read

The Muslim Council of Britain (MCB) has elected its first female secretary general.

Zara Mohammed, a masters graduate in human rights law and a training and development consultant, was elected to Britain’s largest umbrella body of mosques, Islamic schools and Muslim associations.

Ms Mohammed is also the first Scottish secretary general of the MCB.

She won the majority of affiliate votes against Ajmal Masroor, an Imam, teacher and broadcaster who was also running for the post.

Ms Mohammed told the PA news agency she felt “humbled and truly honoured” to take on the responsibility.

“I am really grateful for the opportunity and the trust that the delegates and the MCB have put in me to carry this role forward,” she said.

“Being a young female, it is quite a good representation of the future leadership that we need to see now.”

She said she hoped her election would inspire confidence in other young women.

She added: “I think women sometimes hesitate to take on leadership roles even though they are more than qualified to do so.

“It is really important to engage young people, engage more women and diversify the organisation and the work we are doing.”

As part of her manifesto, she pledged to help develop practical solutions to the Covid-19 pandemic.

She said: “We want to challenge misinformation and we want to continue to promote the guidance, the clarity and reassure the community as part of the united and national effort.

“So definitely promoting the vaccine, encouraging our communities to follow the guidance and keep safe. So that will definitely be at the forefront of the work we are continuing doing.”

Islamaphobia is a “pervasive” issue she said wanted to continue to challenge, as well as looking at how ethnic minority communities have been impacted during the pandemic.

London mayor Sadiq Khan congratulated Ms Mohammed and said it was “terrific” to see her elected.

Ms Mohamed had previously served as assistant secretary general for the MCB.

She succeeded Harun Khan, who completed the maximum of four years as the head of the organisation.

Mr Khan said: “I wish the very best of success to Zara Mohammed — may she continue to lead this organisation to greater heights for the betterment of our communities across the country.”

Latest stories

  • Gordon Ramsay criticised for commenting on woman's teeth during 'Saturday Night Takeaway' game

    The celebrity chef is under fire on Twitter after making a 'humiliating' remark about a woman's teeth.

  • Rishi Sunak plots tax raid on parcels and freelance workers

    Rishi Sunak is plotting a new tax on online deliveries next month and a raid on the self-employed later this year, The Telegraph can reveal. The Chancellor will use Wednesday's Budget to announce a £5 billion fund to help high street pubs, restaurants and non-essential shops that have remained closed as a result of the Covid lockdown. On March 23 – dubbed "tax day" in Whitehall – he will then unveil a series of consultations on further tax increases to start paying for the £300 billion cost of dealing with the virus crisis. The Telegraph has learnt that this will include options to tax online retail more heavily, including the possibility of a new green tax on every internet delivery, alongside other online tax ideas. However, it is understood that he has turned his back on a mooted windfall tax on the "excess profits" of internet companies. Mr Sunak is also planning to use a Budget in the autumn to increase National Insurance Contributions paid by Britain's 4.5 million self-employed, arguing that they too benefited from state support in the pandemic. A Treasury source said: "The idea of an online sales tax is being looked at as part of the business rates review. "Responses to the consultation are being considered in the round, but the Chancellor is cognisant of the need to level up the playing field between the high street and online taxation."

  • Nearly a quarter of NHS staff in London are refusing Covid vaccines

    Almost a quarter of NHS staff in some parts of the country are refusing Covid jabs, with official statistics showing more than 200,000 health and care workers putting patients at risk. NHS figures show that 91 percent of front line healthcare staff across the country have taken up the offer of a vaccine, but that dips to 76 per cent in London – the worst refusal rate. In total, more than 41,000 front line healthcare workers in the capital, including medics, hospital porters, cleaners and laboratory staff, have not had the jab. The national picture among care home staff is even worse, with uptake of less than 73 percent. The statistics show that around 106,000 front line healthcare staff and more than 121,000 care workers have yet to take up the vaccine. Last week, Prof Chris Whitty, the chief medical officer, said NHS and care home staff had a "professional responsibility" to get vaccinated, while the Queen said those who refuse the vaccine "ought to think about other people rather than themselves".

  • Germany urged to follow Britain’s vaccine strategy as regulators look set to approve AstraZeneca for over 65s

    Germany was under pressure to change its covid vaccination strategy yesterday/SUN after the country's top vaccine regulator acknowledged that advice against giving the AstraZeneca jab to over 65s had been flawed. The announcement came as a term of German scientists called on the government to follow the UK in delaying second doses after a study showed it could save up to 15,000 lives. Thomas Mertens, the head of Germany’s Standing Committee on Vaccination (Stiko), said on Saturday that the country was likely to change its controversial guidelines against not to give the AstraZeneca vaccine to over 65s, saying errors had been made. Promising “a new, updated recommendation very soon”, Mertens said: “somehow the whole thing went very badly”. “We had the data that we had and based on this data we made the recommendation. But we never criticized the vaccine. We only criticised the fact that the data situation for the age group over 65 was not good or not sufficient,” he said on Germany’s ZDF news network.

  • Nearly two million people age 60 to 63 to be offered Covid vaccine

    Nearly two million people aged 60 to 63 in England are being invited to book a coronavirus jab as part of the continued expansion of the vaccine programme. NHS England said that the letters will start landing on doormats from Monday, explaining how people can make an appointment to get jabbed through the national booking service. They have been sent out after more than three in four people aged 65 to 70 took up the offer of a vaccination, it added. It comes as leaders from 60 of the UK's black majority churches joined forces on Sunday to show their support for the Covid-19 vaccine to their congregations. They will say they support the rollout of the Covid-19 vaccine programme, and urge their congregations to seek out the facts about the vaccine from trusted sources. They will also say that they have either already been vaccinated or that they will get the vaccine when it is their turn. The alliance of Christian leaders, which includes Bishop of Dover the Rt Rev Rose Hudson-Wilkin, said they felt compelled to act after data suggested black people are among those most likely to be hesitant about receiving the Covid-19 vaccine. Bishop Hudson-Wilkin said: "When you are offered the Covid vaccine, please take it. "This is our chance to show we care for ourselves and our neighbours. "Don't let misinformation rob you of your opportunity to protect yourself and others." This initiative has been organised by Christian umbrella organisations Churches Together in England, Evangelical Alliance and YourNeighbour.

  • Ant and Dec forced to apologise after Gordon Ramsay ‘swears’ on Saturday Night Takeaway

    Ant and Dec joked they had installed a ‘bleeper machine’ for the notoriously sweary chef

  • Budget 2021: Sunak’s £5bn plan to rescue high streets from collapse

    Budget 2021: Sunak’s £5bn plan to rescue high streets from collapse. Grants will be offered to stricken shops and pubs but NHS fears its pleas for cash will be ignored

  • NHS hospital bosses urge ministers to increase ICU beds in England

    NHS hospital bosses urge ministers to increase ICU beds in England . Expansion of capacity must be lasting legacy of Covid-19, says NHS Providers chief executive

  • Debbie McGee says she and Paul Daniels' son have mended their relationship after estate dispute

    Paul Daniels Jr. previously referred to his late father's wife as a 'witch'.

  • Republican predicts Trump won’t be party’s presidential nominee in 2024

    Republican predicts Trump won’t be party’s presidential nominee in 2024. Senator Bill Cassidy points to seats lost in House and Senate during Trump presidency and says ‘if we idolize one person, we will lose’

  • German states call for unused AstraZeneca vaccine to be given to younger people

    Several German states called on Sunday for unused AstraZeneca coronavirus vaccines to be given to younger people, as worries about side effects and efficacy, as well as a recommendation it be used only for under 65s, have meant low take-up of available doses. The German health ministry said this week it had administered only 15% of the AstraZeneca shots it has available, confirming concerns that Germans were being selective, slowing vaccination efforts. Elderly people are first in line to be vaccinated, but Germany has recommended that the AstraZeneca vaccine be given only to people aged 18 to 64.

  • Public backs new taxes on wealthy and business to pay for Covid debt

    Chancellor unveils £5bn ‘restart grants’ for pubs, shops and restaurants

  • 20ft-long king cobra caught in family's home

    A 20ft-long deadly cobra sparked panic after it was caught slithering through a family's home.

  • Covid ‘likely to get worse again’ as new variants spread, Biden warns

    ‘The current improvement could reverse’, says president of rising infections

  • Le Creuset vs Aldi cast iron cookware: Can the 11 times cheaper casserole dish beat the market leader?

    Not all cooking pots are made equal. Or are they? We put them to the test

  • Britain has a moral and legal obligation to Shamima Begum

    Britain has a moral and legal obligation to Shamima BegumHowever monstrous her actions in joining Isis, her citizenship isn’t conditional because her parents were born abroad Shamima Begum: deprived of British citizenship. Photograph: PA

  • Court papers reveal reason for Kim Kardashian and Kanye West divorce

    Kim Kardashian West has cited “irreconcilable differences” as the reason she is divorcing rapper Kanye West. The reality TV star filed divorce papers with an LA court that also confirmed she is seeking joint custody of their four children - North, seven, Saint, five, Chicago, three, and Psalm, one. The businesswoman has enlisted the services of lawyer Laura Wasser, who earned the title “disso queen” thanks to her work sorting out the divorces of high-profile celebrities.

  • Revealed: Rishi Sunak’s £5bn lifeline to help the High Street recover from Covid

    Pubs, restaurants, shops and other businesses hit hardest by the coronavirus pandemic will be boosted by a £5 billion grant scheme to help them reopen as the lockdown is eased. Chancellor Rishi Sunak will announce the “restart grants” worth up to £6,000 per premises to help non-essential retailers reopen and trade safely at his Budget on Wednesday.

  • US approves Johnson & Johnson's single-shot Covid-19 vaccine

    The U.S. is getting a third vaccine to prevent COVID-19, as the Food and Drug Administration on Saturday cleared a Johnson & Johnson shot that works with just one dose instead of two. Health experts are anxiously awaiting a one-and-done option to help speed vaccinations, as they race against a virus that already has killed more than 510,000 people in the U.S. and is mutating in increasingly worrisome ways.The FDA said J&J’s vaccine offers strong protection against what matters most: serious illness, hospitalizations and death. One dose was 85% protective against the most severe COVID-19 illness, in a massive study that spanned three continents — protection that remained strong even in countries such as South Africa, where the variants of most concern are spreading.“This is really good news,” Dr. Francis Collins, director of the National Institutes of Health, told The Associated Press Saturday. “The most important thing we can do right now is to get as many shots in as many arms as we can.”J&J initially is providing a few million doses and shipments to states could begin as early as Monday. By the end of March, J&J has said it expects to deliver 20 million doses to the U.S., and 100 million by summer.J&J also is seeking authorization for emergency use of its vaccine in Europe and from the World Health Organization. Worldwide, the company aims to produce about 1 billion doses globally by the end of the year. On Thursday, the island nation of Bahrain became the first to clear its use.“This is exciting news for all Americans, and an encouraging development in our efforts to bring an end to the crisis,” President Joe Biden said in a statement. “But I want to be clear: this fight is far from over,” he added, encouraging people to stick with masks and other public health measures.On Sunday, a U.S. advisory committee will meet to recommend how to prioritize use of the single-dose vaccine. And one big challenge is what the public wants to know: Which kind is better?“In this environment, whatever you can get — get,” said Dr. Arnold Monto of the University of Michigan, who chaired an FDA advisory panel that unanimously voted Friday that the vaccine’s benefits outweigh its risks.Data is mixed on how well all the vaccines being used around the world work, prompting reports in some countries of people refusing one kind to wait for another.In the U.S., the two-dose Pfizer and Moderna shots were 95% protective against symptomatic COVID-19. J&J’s one-dose effectiveness of 85% against severe COVID-19 dropped to 66% when moderate cases were rolled in. But there’s no apples-to-apples comparison because of differences in when and where each company conducted its studies, with the Pfizer and Moderna research finished before concerning variants began spreading.NIH’s Collins said the evidence shows no reason to favor one vaccine over another.“What people I think are mostly interested in is, is it going to keep me from getting really sick?” Collins said. “Will it keep me from dying from this terrible disease? The good news is all of these say yes to that.”Also, J&J is testing two doses of its vaccine in a separate large study. Collins said if a second dose eventually is deemed better, people who got one earlier would be offered another.The FDA cautioned that it’s too early to tell if someone who gets a mild or asymptomatic infection despite vaccination still could spread the virus.There are clear advantages aside from the convenience of one shot. Local health officials are looking to use the J&J option in mobile vaccination clinics, homeless shelters, even with sailors who are spending months on fishing vessels — communities where it’s hard to be sure someone will come back in three to four weeks for a second vaccination.The J&J vaccine also is easier to handle, lasting three months in the refrigerator compared to the Pfizer and Moderna options, which must be frozen.“We’re chomping at the bit to get more supply. That’s the limiting factor for us right now,” said Dr. Matt Anderson of UW Health in Madison, Wisconsin, where staffers were readying electronic health records, staffing and vaccine storage in anticipation of offering J&J shots soon.The FDA said studies detected no serious side effects. Like other COVID-19 vaccines, the main side effects of the J&J shot are pain at the injection site and flu-like fever, fatigue and headache.An FDA fact sheet for vaccine recipients says there is “a remote chance” that people may experience a severe allergic reaction to the shot, a rare risk seen with the Pfizer and Moderna vaccines. Such reactions are treatable, and vaccine recipients are supposed to be briefly monitored after the injection.The vaccine has been authorized for emergency use in adults 18 and older for now. But like other manufacturers, J&J is about to study how it works in teens before moving to younger children later in the year, and also plans a study in pregnant women.All COVID-19 vaccines train the body to recognize the new coronavirus, usually by spotting the spikey protein that coats it. But they’re made in very different ways.J&J’s shot uses a cold virus like a Trojan horse to carry the spike gene into the body, where cells make harmless copies of the protein to prime the immune system in case the real virus comes along. It’s the same technology the company used in making an Ebola vaccine, and similar to COVID-19 vaccines made by AstraZeneca and China’s CanSino Biologics.The Pfizer and Moderna vaccines are made with a different technology, a piece of genetic code called messenger RNA that spurs cells to make those harmless spike copies.The AstraZeneca vaccine, already used in Britain and numerous other countries, is finishing a large U.S. study needed for FDA clearance. Also in the pipeline, Novavax uses a still different technology, made with lab-grown copies of the spike protein, and has reported preliminary findings from a British study suggesting strong protection.Still other countries are using “inactivated vaccines,” made with killed coronavirus by Chinese companies Sinovac and Sinopharm.(AP)

  • With 511,000 Americans dead from coronavirus, Republicans are outraged at Amazon pulling an anti-trans book

    With more than 511,000 Americans dead from coronavirus, a group of Republicans have vowed to take action.